Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial

BACKGROUND: Atrial fibrillation (AFib) is a common comorbidity in HF and affects patients’ outcome. We sought to assess the effects of serelaxin in patients with and without AFib. METHODS: In a post hoc analysis of the RELAX-AHF trial, we compared the effects of serelaxin on efficacy end points, saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippatos, Gerasimos, Farmakis, Dimitrios, Metra, Marco, Cotter, Gad, Davison, Beth A., Felker, G. Michael, Greenberg, Barry H., Hua, Tsushung A., Pang, Peter S., Ponikowski, Piotr, Qian, Min, Severin, Thomas A., Voors, Adriaan A., Teerlink, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511317/
https://www.ncbi.nlm.nih.gov/pubmed/28150186
http://dx.doi.org/10.1007/s00392-016-1074-x

Ejemplares similares

Ejemplares similares